-
Pfizer Lung Drug Stops Deadly Child …
Pfizer Inc.’s Xalkori, a drug that targets lung cancer caused by a gene defect, wiped o … more…
-
Telik Announces the Publication of Two …
PALO ALTO, Calif. - Telik, Inc. announced two publications in the Journal of Hematology … more…
-
Analysis of Rilotumumab Data Identifies …
THOUSAND OAKS, Calif. - Amgen announced results from an exploratory biomarker analysis … more…
-
Amgen's BiTE Antibody Blinatumomab …
THOUSAND OAKS, Calif. - Amgen announced updated results from a Phase 2 study that showed … more…
-
Intellect Neurosciences Expands Its …
NEW YORK - Intellect Neurosciences, Inc., a biopharmaceutical company engaged in the … more…
Treatment News
New Treatment for Tropical Disease
| More
Thursday, December 22, 2011
A breakthrough may be near in treatment for a disease that affects more than 70 million people in South-East Asia.
Lymphatic filariasis, commonly known as elephantiasis, is one of the oldest and most debilitating tropical diseases.
Spread by mosquitoes, the disease causes severe disfigurement which can lead to permanent disability.
Now a new treatment is being developed by the Drugs for Neglected Diseases Initiative.
Mass treatment
The initiative is supported by the Pasteur Institute and the World Health Organisation.
Dr Robert Don told Radio Australia's Connect Asia the disease, at present, is treated by "mass drug administration".
"Everyone who is potentially at risk is given one tablet once a year, which kills the juvenile or the baby worms, and that stops the worms from spreading from one person to the next," he said.
"That continues until the adult worms die in normally infected people."
"What we're looking at is a drug that kills the adult worms, so instead of treating several times for many years, we hope we can reduce that to one or two years," Dr Don said.
©2011 ABC
Source: ABC Radio Australian News
Log in now to comment.